Literature DB >> 23413899

Are dysfunctional monocyte-derived dendritic cells in cancer an explanation for cancer vaccine failures?

José Alexandre Marzagão Barbuto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23413899     DOI： 10.2217/imt.12.153

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  4 in total

1.  Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence.

Authors:  Mariana P Pinho; Guilherme A Lepski; Roberta Rehder; Nadia E Chauca-Torres; Gabriela C M Evangelista; Sarah F Teixeira; Elizabeth A Flatow; Jaqueline V de Oliveira; Carla S Fogolin; Nataly Peres; Analía Arévalo; Venâncio Alves; José A M Barbuto; Patricia C Bergami-Santos
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

Review 2.  Dendritic Cell-Derived Exosomes may be a Tool for Cancer Immunotherapy by Converting Tumor Cells into Immunogenic Targets.

Authors:  Graziela Gorete Romagnoli; Bruna Barbosa Zelante; Patrícia Argenta Toniolo; Isabella Katz Migliori; José Alexandre M Barbuto
Journal:  Front Immunol       Date:  2015-01-19       Impact factor: 7.561

Review 3.  Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy.

Authors:  Thiago A Patente; Mariana P Pinho; Aline A Oliveira; Gabriela C M Evangelista; Patrícia C Bergami-Santos; José A M Barbuto
Journal:  Front Immunol       Date:  2019-01-21       Impact factor: 7.561

4.  Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells.

Authors:  Fabrício C Machado; Natália Girola; Vera S C Maia; Patrícia C Bergami-Santos; Alice S Morais; Ricardo A Azevedo; Carlos R Figueiredo; José A M Barbuto; Luiz R Travassos
Journal:  Front Immunol       Date:  2020-01-15       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.